Two genes in the major histocompatibility complex control immune response.

PubWeight™: 4.08‹?› | Rank: Top 1%

🔗 View Article (PMID 50559)

Published in Nature on July 10, 1975

Authors

A J Munro, M J Taussig

Articles citing this

Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52

Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med (1979) 5.22

Mycobacterium. Bacteriol Rev (1977) 3.20

T-lymphocyte-enriched murine peritoneal exudate cells. II. Genetic control of antigen-induced T-lymphocyte proliferation. J Exp Med (1976) 2.27

Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses. J Exp Med (1977) 2.16

Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. III. Dual gene control of the T-cell-mediated suppression of the antibody response. J Exp Med (1976) 2.12

Expression of individual Ia specificities on T and B cells. I. Studies with mitogen-induced blast cells. J Exp Med (1976) 2.08

The role of H-2 linked genes in helper T-cell function. IV. Importance of T-cell genotype and host environment in I-region and Ir gene expression. J Exp Med (1978) 2.00

Antigen-specific T-cell-mediated suppression. I. Induction of L-glutamic acid60-L-alanine30-L-tyrosine10 specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen. J Exp Med (1978) 1.84

The requirement for two complementing Ir-GLphi immune response genes in the T-lymphocyte proliferative response to poly-(Glu53Lys36Phe11). J Exp Med (1976) 1.81

The role of H-2-linked genes in helper T-cell function. III. Expression of immune response genes for trinitrophenyl conjugates of poly-L(Tyr, Glu)-poly-D,L-Ala--poly-L-Lys in B cells and macrophages. J Exp Med (1978) 1.61

Inhibition of dual Ir gene-controlled T-lymphocyte proliferative response to poly (Glu56Lys35Phe9)n with anti-Ia antisera directed against products of either I-A or I-C subregion. Proc Natl Acad Sci U S A (1978) 1.55

Cytotoxic T-cell responses to H-Y: mapping of the Ir genes. J Exp Med (1978) 1.53

Control of t-lymphocyte and B-lymphocyte activation by two complementing Ir-GLphi immune response genes. J Exp Med (1976) 1.52

The role of H-2-linked genes in helper T-cell function. I. In vitro expression in B cells of immune response genes controlling helper T-cell activity. J Exp Med (1977) 1.49

Gene complementation in the T-lymphocyte proliferative response to poly (Glu55Lys36Phe9)n. A demonstration that both immune response gene products must be expressed in the same antigen-presenting cell. J Exp Med (1979) 1.45

The role of H-2-linked genes in helper T-cell function. VI. Expression of Ir genes by helper T cells. J Exp Med (1979) 1.33

Inclusion group systems and cis-trans effects in responses controlled by the two complementing Ir-GLphi genes. J Exp Med (1976) 1.29

Regulatory mechanisms in cell-mediated immune responses. IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes. J Exp Med (1976) 1.27

Requirement for T cells in the production of migration inhibitory factor. J Exp Med (1975) 1.26

Genetic control of the immune response to staphylococcal nuclease. III. Time-course and correlation between the response to native nuclease and the response to its polypeptide fragments. J Exp Med (1977) 1.20

Nature of T-cell macrophage interaction in helper-cell induction in vitro. II. Two stages of T-helper-cell differentiation analyzed in irradiation and allophenic chimeras. J Exp Med (1979) 1.20

Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies. J Exp Med (1982) 1.19

Spontaneous autoimmunization to GIX cell surface antigen in hybrid mice. J Exp Med (1976) 1.16

Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGu)-poly(DLAla)--poly(LLys). I. Expression of the genetic defect at two phases of the immune process. J Exp Med (1980) 1.11

Chemical characterization of murine Ia alloantigens determined by the i-E/i-C subregions of the H-2 complex. Proc Natl Acad Sci U S A (1977) 1.09

Induction of human antigen-specific and non-specific helper factors in vitro. Clin Exp Immunol (1979) 1.03

Structural characteristics of the alloantigens determined by the major histocompatibility complex of the guinea pig. J Exp Med (1976) 0.99

In vitro studies on H-2 linked unresponsiveness. 1. Normal helper cells to (T,G)-A-L and GAT in low and non-responder mice. Immunology (1977) 0.99

Selective production of human antigen specific helper factor from normal volunteers: implications for human Ir genes. Clin Exp Immunol (1979) 0.97

Ia antigenic specificities are oligosaccharide in nature: hapten-inhibition studies. J Exp Med (1977) 0.96

Coupled complementation of immune response genes controlling responsiveness to the H-2.2 alloantigen. J Exp Med (1977) 0.94

Immunopathology of the lens. III. Humoral and cellular immune responses to autologous lens antigens and their roles in ocular inflammation. Br J Ophthalmol (1977) 0.93

Antigen-specific T-cell factors. Immunology (1980) 0.89

Antigen-specific T cell-mediated suppression. V. H-2-linked genetic control of distinct antigen-specific defects in the production and activity of L-glutamic acid50-L-tyrosine50 suppressor factor. J Exp Med (1980) 0.87

Partial chemical characterization of Ia antigens derived from murine thymocytes. Proc Natl Acad Sci U S A (1977) 0.84

Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response. Immunology (1979) 0.84

Genetic control of the immune response to staphylococcal nuclease. VII. Role of non-H2-linked genes in the control of the anti-nuclease antibody response. J Exp Med (1978) 0.83

The immune response of allophenic mice to the synthetic polymer L-glutamic acid, L-lysine, L-phenylalanine. II. Lack of gene complementation in two nonresponder strains. J Exp Med (1977) 0.83

Antigen-specific and non-specific helper activities derived from supernatants of human influenza virus-specific T-cell lines. Immunology (1983) 0.83

Role of membrane structures in B-lymphocyte activation. The effect of binding anti-immunoglobulin, aggregated IgG and immune complexes. Immunology (1976) 0.82

Expression of a single major histocompatibility complex locus controls the immune response to poly-L-(tyrosine, glutamic acid)-poly-DL-alanine-poly-L-lysine. J Exp Med (1978) 0.81

Cell-bound helper and suppressor factors in primate lymphocytes. Clin Exp Immunol (1982) 0.81

Inhibition of T-antigen-binding cells by idiotypic antisera. J Exp Med (1977) 0.78

The immune response to oxidized ferredoxin. I. Specificity of the response to the amino terminal determinant. Immunology (1976) 0.78

Interactions between T and B cells: a review. J R Soc Med (1979) 0.77

Purification and properties of a factor from leukaemic T cells which non-specifically enhances the antibody response. Immunology (1981) 0.75

'Electrochemical stimulation' of the hypothalamus--a demonstration that this technique does not cause the direct excitation of peptidergic neurones [proceedings]. J Physiol (1978) 0.75

Genetic control of the antibody response to poly(L Tyr, L Glu)-poly(DL Ala)--poly(L Lys) in mice: analysis of (low responder x low responder)F1 hybrids. Immunology (1982) 0.75

Participation of diffusible products in the in vivo immune primary response to red blood cells. Immunology (1981) 0.75

Articles by these authors

Antigen-specific T-cell factor in cell cooperation. Mapping within the I region of the H-2 complex and ability to cooperate across allogeneic barriers. J Exp Med (1975) 4.64

Studies on the nature of polysomes. Biochem J (1964) 4.18

Antigen-specific T-cell factor in cell cooperation: physical properties and mapping in the left-hand (K) half of H-2. J Exp Med (1974) 4.10

T cell factor which can replace T cells in vivo. Nature (1974) 3.10

Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci U S A (2000) 2.63

Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality. Eur J Cancer (2012) 2.26

Production of an H--2-related suppressor factor by a hybrid T-cell line. Nature (1979) 2.22

Antigen-specific T-cell factors in the genetic control of the immune response to poly(Tyr,Glu)-polyDLAla--polyLys. Evidence for T- and B-cell defects in SJL mice. J Exp Med (1975) 1.98

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood (1983) 1.80

Bone metastases: pathophysiology and management policy. J Clin Oncol (1991) 1.70

Carcinoma of the prostate: results of radical radiotherapy (1970-1985). Int J Radiat Oncol Biol Phys (1993) 1.61

Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res (1997) 1.56

Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for a substrate specificity. J Biol Chem (2000) 1.55

Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol (1997) 1.53

Cooperation across the histocompatibility barrier. Nature (1975) 1.51

Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. Int J Radiat Oncol Biol Phys (1992) 1.45

Structure of an antigen-specific suppressor factor produced by a hybrid T-cell line. Nature (1979) 1.43

Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS (1992) 1.43

Comparison of the direct antiglobulin rosetting reaction with the mixed antiglobulin rosetting reaction for the detection of immunoglobulin on lymphocytes. J Immunol Methods (1977) 1.42

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies. J Clin Oncol (1987) 1.42

Dysphagia after fast neutron therapy to head and neck. Br J Radiol (1990) 1.39

Particle matters. Br J Radiol (2006) 1.39

Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. Nature (1993) 1.38

Antigenic competition. Curr Top Microbiol Immunol (1973) 1.34

A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol) (1996) 1.31

The genetic basis of antibody specificity. Annu Rev Microbiol (1970) 1.31

Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev (2005) 1.25

Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). Nucleic Acids Res (2001) 1.17

Characterization of a progesterone-binding, three-domain antibody fragment (VH/K) expressed in Escherichia coli. Immunology (1995) 1.16

Control of haemoglobin synthesis: a difference in the size of the polysomes making alpha and beta chains. Nature (1968) 1.15

Demonstration of suppressor T cells in a population of 'educated' T cells. Nature (1974) 1.13

Extragonadal presentations of germ cell tumours. Br J Urol (1983) 1.12

Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. J Mol Biol (1993) 1.10

Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes. J Mol Biol (1994) 1.10

T cell dependence of B cell unresponsiveness in vitro. Eur J Immunol (1974) 1.10

Studies on antigenic competition. II. Abolition of antigenic competition by antibody against or tolerance to the dominant antigen: a model for antigenic competition. Immunology (1972) 1.08

Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins. Structure (2001) 1.07

Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes. Clin Exp Immunol (1981) 1.06

Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003-2007. Br J Cancer (2011) 1.06

Induction of an antibody response in cultures of human peripheral blood lymphocytes. J Exp Med (1976) 1.04

Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a. FASEB J (1999) 1.01

Rapid appearance of M cells after microbial challenge is restricted at the periphery of the follicle-associated epithelium of Peyer's patch. Lab Invest (1999) 1.01

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer. Vaccine (1996) 1.00

Antigen-specific T-cell factor in cell cooperation and genetic control of the immune response. Fed Proc (1976) 0.99

Selection of a human anti-progesterone antibody fragment from a transgenic mouse library by ARM ribosome display. J Immunol Methods (1999) 0.98

Antigenic competition and genetic control of the immune response. A hypothesis for intramolecular competition. Cell Immunol (1973) 0.97

T-cell help in human in vitro antibody-producing systems: role of inhibitory T cells in masking allogeneic help. Cell Immunol (1981) 0.96

A charge difference between an intracellular and secreted mouse myeloma globulin. Biochem Biophys Res Commun (1966) 0.95

Inhibition by soluble ribonucleic acid of stimulatory effect of liver template ribonucleic acid. Biochem J (1966) 0.94

Efficacy and specificity of monoclonal antibodies to progesterone in preventing the establishment of pregnancy in the mouse. J Endocrinol (1988) 0.94

Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumours. Br J Cancer (1985) 0.93

Bacteriophage linked assays for antibodies to protein antigens. Immunology (1970) 0.93

Surface T-and B-cell markers on murine lymphomas and plasmacytomas. Immunology (1974) 0.93

Analysis of an anti-progesterone antibody: variable crystal morphology of the Fab' and steroid-Fab' complexes. Immunology (1987) 0.92

Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes. J Immunol (1999) 0.92

Results of a policy of surveillance in stage I testicular seminoma. Int J Radiat Oncol Biol Phys (1993) 0.92

An indirect anti-immunoglobulin rosetting reaction to detect alloantibodies to human lymphocytes. J Immunol Methods (1977) 0.91

Studies on antigenic competition. I. Antigenic competition between the Fc and Fab fragments of rabbit IgG in mice. Immunology (1971) 0.91

Successful construction of chimaeric rabbit. Nature (1974) 0.91

Is placental alkaline phosphatase (PLAP) a useful marker for seminoma? Eur J Cancer (1990) 0.91

Anti-idiotypic sera against monoclonal anti-progesterone antibodies: production in rabbits and rats and characterization of specificity. Immunology (1986) 0.90

Antibody-guided irradiation of malignant pleural and pericardial effusions. Br J Cancer (1986) 0.89

Antigen-specific T-cell factors. Immunology (1980) 0.89

Functional expression of a single-chain anti-progesterone antibody fragment in the cytoplasm of a mutant Escherichia coli. Nucleic Acids Res (1995) 0.89

Antigen-specific helper factors in rabbit lack both V and C region Ig determinants. Nature (1977) 0.88

The management of testicular seminoma: Edinburgh 1970-1981. Br J Cancer (1987) 0.88

Suppressor T cell product, which depresses the passive transfer of contact sensitivity, shares epitope(s) with the major histocompatibility complex. Int Arch Allergy Appl Immunol (1977) 0.87

Studies on the mechanism of antigenic competition: analysis of competition between synthetic polypeptide antigens. Eur J Immunol (1972) 0.87

The reliability of clinical assessment of Parkinson's disease. J Neurol Neurosurg Psychiatry (1984) 0.86

Detection of acceptor sites on human lymphocytes for antigen-specific T cell factors. Nature (1977) 0.86

A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer. Br J Cancer (1986) 0.86

The major histocompatibility system and cell interactions in man. Transplant Proc (1981) 0.85

Studies on the role of HLA-DR in macrophage-T cell interactions. Tissue Antigens (1981) 0.85

Crystallization of a complex between the Fab fragment of a human immunoglobulin M (IgM) rheumatoid factor (RF-AN) and the Fc fragment of human IgG4. Immunology (1996) 0.85

A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer. Br J Cancer (1986) 0.85

The formation of pyrrolid-2-one-5-carboxylic acid at the N-terminus of immunoglobulin G heavy chain. Biochem J (1972) 0.84

Rapid discovery of protein interactions by cell-free protein technologies. Biochem Soc Trans (2007) 0.84

Cooperation across the histocompatibility barrier: H2d T cells primed to antigen in an H-2d environment can cooperate with H-2k B cells. J Exp Med (1976) 0.84

Complement-independence of tolerance induction. Eur J Immunol (1974) 0.84

Characterization of germ-line genes of the VGAM3.8 VH gene family from BALB/c mice. J Immunol (1992) 0.83

Monoclonal antibodies against progesterone: effect of steroid-carrier coupling position on antibody specificity. J Steroid Biochem Mol Biol (1994) 0.82

Response of mice to rabbit Fab' 2 and Fab'. Thymus independence of IgM response and thymus dependence of IgG response. Immunology (1972) 0.82

External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability. Radiother Oncol (1996) 0.82

Antigen-induced suppression in man: non-specific suppression mediated via OKT8+ cells. Immunology (1984) 0.81

Prolonged survival of cultured keratinocyte allografts in the nonimmunosuppressed mouse. Transplantation (1987) 0.81

Studies on antigenic competition. 3. Is there a competitive step in tolerance induction? Eur J Immunol (1972) 0.81

Complementation of immune response genes for (T,G)-A-L. Nature (1977) 0.81

Pharmacokinetics of ceftazidime in normal subjects. J Antimicrob Chemother (1981) 0.81

Inhibition of pregnancy before and after implantation in rats with monoclonal antibody against progesterone. Contraception (1988) 0.81

Characterization of an antigen-specific factor from a hybrid T-cell line. Ann N Y Acad Sci (1979) 0.81

Hypersensitivity reactions to acetylsalicylic acid. I. Detection of antibodies in human sera using acetylsalicylic acid attached to proteins through the carboxyl group. Clin Exp Immunol (1971) 0.80

Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay. Clin Exp Rheumatol (2003) 0.80

The induction of an immune response in vitro to a protein antigen (rabbit Fab'2). Immunology (1970) 0.80

The demonstration of the involvement of antibody in the in vitro lysis of chicken erythrocytes by allergized spleen cells. Immunology (1974) 0.80

Blocking of pregnancy in mice by immunization with anti-idiotype directed against monoclonal anti-progesterone antibody. Proc Natl Acad Sci U S A (1989) 0.80

Hybridization between T and B lymphoma cell lines. Immunology (1980) 0.80

Electron microscope examination of free IgA molecules and of their complexes with antigen. Nature (1971) 0.79